Atea Pharmaceuticals Inc

AVIR NASDAQ Santé & Biotech États-Unis US04683R1068
4.35 $
3.12 %

Atea Pharmaceuticals est impliquée dans le développement de thérapies antivirales pour les infections sévères, notamment pour la COVID-19.

Performance & Momentum

6 Months 42.54 %
1 Year 42.09 %
3 Years 7.16 %
5 Years 80.80 %

Similar stocks to Atea Pharmaceuticals Inc

Anantys Community

Be the first to share your analysis on Atea Pharmaceuticals Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases